LIVMARLI Now Approved in Japan for ALGS and PFIC
LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and ...
How to Watch the Year 5 ALGS Open - Tickets, Teams, & More
Apex Legends remains one of the most popular first-person shooters year after year, and its esports scene continues to grow ...
Inaugural ALGS Open Launches in New Orleans with $1M Prize Pool
The inaugural ALGS Open is set to begin at the Ernest N. Morial Convention Center from May 1-4, 2025, marking what is ...
ALGS returns to the United States for biggest Apex LAN in history
The ALGS Open will take place in New Orleans, LA from May 1-4, with a massive 160 Apex teams participating in the first ...
Aligos Therapeutics presents positive data at APASL2025
Aligos Therapeutics (ALGS) announced positive data from three oral presentations at the 34th Annual Meeting of the Asian Pacific Association ...
Mirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell Call
Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...
Ten option delistings on March 24th
Option delistings effective March 24th include Aligos Therapeutics (ALGS), Allbirds (BIRD), Biotricity Inc (BTCY), DWTX Stock (DWTX), Dixie ...
HC Wainwright Has Pessimistic Outlook of ALGS Q1 Earnings
Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E.